List of insiders holdings for Jasper Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
ROCHE HOLDING LTD ROCHE FINANCE LTD 10% Owner | 2023-02-13 16:49:22 | 4,624,606 0 | 4,624,606 | Form 13G |
HOFFEN HOWARD I FORMER DIRECTOR Director | 2021-09-28 16:32:58 | 0 2,300,000 | 2,300,000 | Form 4 |
Clifford Kenneth F FORMER OFFICER | 2021-09-28 16:33:57 | 0 2,300,000 | 2,300,000 | Form 4 |
Amplitude Healthcare Holdings LLC 10% Owner | 2022-04-28 16:25:22 | 1,678,281 0 | 1,678,281 | Form 13G |
Velan Capital Investment Management LP Velan Capital Master Fund LP Avego Healthcare Capital L.P. Velan Capital Holdings LLC Avego Healthcare Capital Holdings LLC Avego Management LLC Velan Capital Management LLC VENKATARAMAN BALAJI Morgan Adam 10% Owner | 2024-02-09 20:40:05 | 0 1,433,828 | 1,433,828 | Form 4 |
Carlyle Group Inc. Carlyle Holdings I GP Inc. Carlyle Holdings I GP Sub L.L.C. Carlyle Holdings I L.P. CG Subsidiary Holdings L.L.C. TC Group LLC Carlyle Investment Management LLC Carlyle Genesis UK LLC Abingworth LLP Abingworth Bioventures VII LP Former 10% Owner | 2024-02-12 18:23:53 | 0 1,066,189 | 1,066,189 | Form 4 |
Qiming U.S. Healthcare Fund II L.P. Qiming U.S. Healthcare GP II LLC MCDADE MARK RIESCHEL GARY E 10% Owner | 2024-02-14 16:18:20 | 928,964 0 | 928,964 | Form 13G |
MARTELL RON President, CEO and Director | 2024-02-20 19:33:18 | 100,000 0 | 100,000 | Form 4 |
Brun Scott C. Director | 2023-06-20 21:48:28 | 94,000 0 | 94,000 | Form 4 |
GLAZER CAPITAL LLC GLAZER PAUL J 10% Owner | 2021-07-12 12:52:22 | 59,397 0 | 59,397 | Form 13G |
Lis William Director | 2023-10-13 18:56:56 | 53,521 0 | 53,521 | Form 4 |
WIGGANS THOMAS G Director | 2023-11-30 16:05:16 | 50,000 0 | 50,000 | Form 4 |
French Anna Louise Director | 2023-06-08 18:41:56 | 47,000 0 | 47,000 | Form 4 |
Nolet Chris Director | 2023-06-08 18:42:54 | 47,000 0 | 47,000 | Form 4 |
Shizuru Judith Anne Director | 2023-06-08 18:43:24 | 47,000 0 | 47,000 | Form 4 |
EMSTER KURT VON Director | 2023-06-08 18:43:52 | 47,000 0 | 47,000 | Form 4 |
Klein Lawrence Otto Director | 2023-06-08 18:44:16 | 47,000 0 | 47,000 | Form 4 |
Kapoor Vishal Director | 2023-06-08 18:44:45 | 47,000 0 | 47,000 | Form 4 |
Tucker Edwin Jonathan Chief Medical Officer | 2024-02-20 19:22:06 | 45,000 0 | 45,000 | Form 4 |
Mahal Jeetinder Singh Chief Operating Officer | 2024-03-12 21:33:11 | 41,481 0 | 41,481 | Form 4 |
CROSS HERB Chief Financial Officer | 2024-02-20 19:27:04 | 40,000 0 | 40,000 | Form 4 |
Heller Kevin N. See Remarks | 2022-03-23 18:04:14 | 7500 0 | 7500 | Form 4 |
Reicin Glenn Director | 2019-11-19 19:58:46 | 0 0 | 0 | Form 3 |
MARIO ERNEST Director | 2019-11-19 19:57:57 | 0 0 | 0 | Form 3 |
ESHELMAN FREDRIC N Director | 2019-11-19 19:56:56 | 0 0 | 0 | Form 3 |
DOLAN PETER R Director | 2019-11-19 19:56:31 | 0 0 | 0 | Form 3 |